Changes in the gene expression profile of gastric cancer cells in response to ibuprofen: A gene pathway analysis

Keyphrases

• Antiproliferative Activity 100%
• Gene Expression Profile 100%
• Gastric Cancer Cells 100%
• Gene Pathway Analysis 100%
• Cell Viability 33%
• Cancer Cells 33%
• DNA Replication 33%
• Cell Cycle Progression 33%
• Flow Cytometry 33%
• Anti-inflammatory Effect 33%
• Cell Proliferation 33%
• Induced Gene 33%
• Cell number 33%
• Non-steroidal Anti-inflammatory Drugs (NSAIDs) 33%
• P53 Expression 33%
• GADD45A 33%
• G1 Phase 33%
• Microarray Technology 33%
• Apoptotic Pathway 33%
• Apoptosis Induction 33%
• G1-S Transition 33%
• 3H-thymidine Incorporation 33%
• Reactive Oxygen Species 33%
• P450 33%
• Cell Cycle Control 33%
• Intracellular Reactive Oxygen Species 33%
• Cellular Alterations 33%
• Checkpoint Pathway 33%
• CDKN1A 33%
• Cell Counting 33%
• Biological Oxidation 33%
• MKN-45 Cells 33%

Immunology and Microbiology

• Cancer Cell 100%
• Gene Expression 100%
• P53 100%
• Antiproliferative Activity 100%
• Cell Cycle 66%
• DNA Synthesis 66%
• Programmed Cell Death 66%
• Cell Proliferation 33%
• Cell Count 33%
• Cell Line 33%
• Cell Viability 33%
• Antiinflammatory Activity 33%
• Cell Cycle Regulation 33%
• Cell Cycle Progression 33%
• Cell Cycle G1 Phase 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Ibuprofen 100%
• Abdominal Cancer 100%
• Protein P53 27%
• Reactive Oxygen Metabolite 18%
• Malignant Neoplasm 9%
• Flow Cytometry 9%
• Cytochrome P450 9%
• Non-Steroidal Anti-Inflammatory Drug 9%
• Antiinflammatory Activity 9%
• Cell Viability 9%
• Thymidine 9%
• Antiproliferative Activity 9%